Huanjing Chen
Optometrist · Novato, CANPI 1518377787
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,469 of the $3,608 with a category attached, or 68.4%. 14 manufacturers reported payments, led by Alcon at 34.5% of the total. Reporting peaked in 2020 at $1,324 and has fallen 98.1% since, to $25 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $62.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Carl Zeiss Meditec, Inc.$482
- Coopervision Inc.$344
- Bausch & Lomb, A Division Of Bausch Health US, LLC$329
- Oyster Point Pharma, Inc.$311
- Bausch & Lomb Americas Inc.$289
- plus $608 from 8 others
Across 112 payments — averaging $1141.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$128K
What the payments were for
- Consulting fees$38011%
- Travel & lodging$65218%
- Food & beverage$2,46968%
- Gifts$371%
- Entertainment$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 13 | $1,244 |
| Carl Zeiss Meditec, Inc. | 4 | $482 |
| Coopervision Inc. | 9 | $344 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $329 |
| Oyster Point Pharma, Inc. | 6 | $311 |
| Bausch & Lomb Americas Inc. | 4 | $289 |
| Eyevance Pharmaceuticals LLC | 4 | $228 |
| AbbVie | 1 | $124 |
| Johnson & Johnson Vision Care, Inc. | 2 | $82 |
| Optos, Inc. | 3 | $71 |
| Sun Pharmaceutical Industries Inc. | 2 | $40 |
| Novartis | 1 | $25 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Alcon Research LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,608 in reported general payments places this provider in the 90th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $338 |
| Latanoprost | 28 | $146 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Novato
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.